Subuphine 8 mg Resoriblett, sublingual

País: Suecia

Idioma: sueco

Fuente: Läkemedelsverket (Medical Products Agency)

Ingredientes activos:

buprenorfinhydroklorid

Disponible desde:

Activase Pharmaceuticals Limited

Código ATC:

N07BC01

Designación común internacional (DCI):

buprenorphine hydrochloride

Dosis:

8 mg

formulario farmacéutico:

Resoriblett, sublingual

Composición:

mannitol Hjälpämne; buprenorfinhydroklorid 8,64 mg Aktiv substans; laktosmonohydrat Hjälpämne

clase:

Apotek

tipo de receta:

Receptbelagt

Área terapéutica:

Buprenorfin

Resumen del producto:

Förpacknings: Blister, 7 tabletter; Blister, 14 tabletter; Blister, 28 tabletter

Estado de Autorización:

Godkänd

Fecha de autorización:

2010-07-02

Información para el usuario

PACKAGE LEAFLET: INFORMATION FOR THE USER
SUBUPHINE 0.4, 2 AND 8 MG SUBLINGUAL TABLETS
buprenorphine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Subuphine is and what it is used for
2.
What you need to know before you take Subuphine
3.
How to take Subuphine
4.
Possible side effects
5.
How to store Subuphine
6.
Contents of the pack and other information.
1.
WHAT SUBUPHINE IS AND WHAT IT IS USED FOR
Subuphine is a medicinal product used in opioid (narcotic) dependence.
Subuphine are used as part of a medical, social and psychological
treatment programme for patients addicted
to opiate (narcotic) drugs.
Treatment is prescribed and monitored by physicians who are
specialists in the treatment of drug
dependence.
Treatment with Subuphine is intended for use in adults and adolescents
over 15 years of age.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE SUBUPHINE
DO NOT TAKE
SUBUPHINE IF YOU:

are allergic to buprenorphine or any of the other ingredients of this
medicine (listed in section 6)

suffer from serious breathing difficulties

suffer from a seriously reduced liver function

suffer from alcoholism or delirium tremens (the “shakes” and
hallucinations)
WARNINGS AND PRECAUTIONS:
Talk to your doctor or pharmacist before taking Subuphine.
Tell your doctor if you have any of the following illnesses before
treatment or develop them during
treatment, as your doctor may need to reduce your dose of Subuphine or
you may need extra treatment to
control them:

have taken morphine o

Ficha técnica

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_